SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.881
AS - Asia 15.536
EU - Europa 10.267
SA - Sud America 2.414
AF - Africa 321
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 55.456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.342
SG - Singapore 5.601
CN - Cina 4.092
IT - Italia 2.807
BR - Brasile 1.879
DE - Germania 1.847
VN - Vietnam 1.767
UA - Ucraina 1.483
HK - Hong Kong 1.291
TR - Turchia 1.104
GB - Regno Unito 853
FI - Finlandia 695
FR - Francia 632
SE - Svezia 502
RU - Federazione Russa 476
JP - Giappone 388
IN - India 316
PL - Polonia 311
CA - Canada 250
MX - Messico 219
BD - Bangladesh 207
AR - Argentina 195
NL - Olanda 191
ID - Indonesia 136
IQ - Iraq 126
ZA - Sudafrica 117
ES - Italia 107
EC - Ecuador 81
CO - Colombia 73
PK - Pakistan 67
LT - Lituania 65
BE - Belgio 62
VE - Venezuela 57
UZ - Uzbekistan 54
CL - Cile 47
MA - Marocco 47
AE - Emirati Arabi Uniti 44
MY - Malesia 44
SA - Arabia Saudita 43
TN - Tunisia 38
AT - Austria 37
CZ - Repubblica Ceca 36
PH - Filippine 35
PY - Paraguay 30
KE - Kenya 29
NP - Nepal 24
JO - Giordania 22
AU - Australia 20
DZ - Algeria 19
EG - Egitto 19
IE - Irlanda 18
AL - Albania 17
IL - Israele 17
UY - Uruguay 17
IR - Iran 15
PE - Perù 15
AZ - Azerbaigian 13
BO - Bolivia 13
RO - Romania 13
LB - Libano 12
PT - Portogallo 12
TW - Taiwan 12
CH - Svizzera 11
KR - Corea 11
OM - Oman 11
BG - Bulgaria 10
PS - Palestinian Territory 10
TH - Thailandia 10
CR - Costa Rica 9
HN - Honduras 9
JM - Giamaica 9
GR - Grecia 8
HR - Croazia 8
HU - Ungheria 8
PA - Panama 8
RS - Serbia 8
ET - Etiopia 7
EU - Europa 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LV - Lettonia 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
MN - Mongolia 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
AO - Angola 5
BH - Bahrain 5
CI - Costa d'Avorio 5
GE - Georgia 5
GT - Guatemala 5
GY - Guiana 5
MK - Macedonia 5
NG - Nigeria 5
NI - Nicaragua 5
QA - Qatar 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
Totale 55.369
Salva come PNG Salva come JPEG
Città #
Singapore 3.655
Ashburn 2.830
Woodbridge 2.407
Fairfield 2.035
San Jose 1.668
Jacksonville 1.590
Chandler 1.581
Houston 1.496
Hong Kong 1.268
Beijing 1.216
Ann Arbor 1.187
Santa Clara 1.164
Wilmington 864
Seattle 835
Cambridge 671
Ho Chi Minh City 593
Izmir 518
Nanjing 490
Dallas 476
Los Angeles 470
Hanoi 427
Tokyo 373
Princeton 361
Milan 358
Ferrara 322
Munich 305
Boardman 299
Lauterbourg 295
New York 283
Warsaw 260
Helsinki 255
Shanghai 196
São Paulo 183
San Diego 172
Nanchang 165
Council Bluffs 152
Shenyang 152
Dearborn 149
Orem 134
London 129
Tianjin 126
Turku 126
Mexico City 125
Addison 111
Hefei 109
Bremen 104
Falkenstein 104
Rome 102
Changsha 100
Hebei 98
Buffalo 95
Montreal 94
Frankfurt am Main 93
Chicago 90
Da Nang 90
Jakarta 80
Brooklyn 76
Haiphong 75
Jiaxing 73
Bologna 72
The Dalles 72
Chennai 70
Toronto 70
Jinan 64
Johannesburg 62
Stockholm 61
Denver 60
Manchester 60
Moscow 60
Rio de Janeiro 60
San Mateo 60
Brussels 57
Norwalk 56
Florence 54
San Francisco 54
Atlanta 53
Mountain View 51
Zhengzhou 51
Baghdad 50
Tashkent 50
Amsterdam 49
Boston 49
Kunming 49
Poplar 49
Phoenix 48
Guangzhou 47
Mumbai 44
Falls Church 43
Belo Horizonte 41
Düsseldorf 38
Orange 36
Auburn Hills 35
Biên Hòa 35
Hải Dương 35
Redwood City 35
Ningbo 33
Verona 32
Ankara 31
Naples 31
Brasília 29
Totale 35.891
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.383
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 633
Pharmacology of Adenosine Receptors: The State of the Art 381
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 328
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 308
A glance at adenosine receptors: Novel target for antitumor therapy 305
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 293
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 283
The A3 adenosine receptor: history and perspectives 275
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 271
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 262
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 259
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 258
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 257
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 255
Adenosine receptors and human melanoma 253
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 252
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 252
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 244
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 243
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 242
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 239
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 239
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 237
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 232
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 231
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 228
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 228
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 227
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 226
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 225
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 224
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 221
Adenosine receptors and cancer 221
Adenosine receptor targeting in health and disease 221
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 219
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 218
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 217
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 216
van't Hoff Based Thermodynamics 216
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 213
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 212
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 212
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 211
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 210
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 210
Agonists and antagonists: Molecular mechanisms and therapeutic applications 210
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 209
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 208
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 208
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 208
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 207
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 206
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 205
Pathological overproduction: the bad side of adenosine 205
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 204
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 202
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 202
Adenosine and lymphocyte regulation 202
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 201
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 200
Binding thermodynamics of 5-HT(1A) receptor ligands 200
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 200
Adenosine receptors in health and disease 200
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 199
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 198
Binding thermodynamics at A1 and A2A adenosine receptors 197
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 196
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 196
Targeting A3 and A2A adenosine receptors in the fight against cancer 196
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 195
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 195
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 193
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 192
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 192
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 192
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 192
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 192
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 191
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 191
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 190
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 190
Adenosine receptors and cancer 190
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 189
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 189
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 188
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 187
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 187
A(2A) adenosine receptors in human peripheral blood cells 186
Farmacologia cellulare e molecolare, sistemi di trasmissione. Trasmissione purinergica. 186
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 186
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 186
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 185
Adenosine in a human model of Hypoxic foam cells 185
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 185
New potent and selective human adenosine A3 receptor antagonists. 184
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 182
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 182
Characterization of the human vascular kinin B2 receptor by binding assays. 180
Totale 23.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.502
Totale 236.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.306 0 0 0 0 0 0 0 0 0 563 511 232
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/20257.724 188 220 612 424 973 666 314 473 1.036 864 1.071 883
2025/202620.000 2.183 823 1.824 2.718 3.007 1.456 2.498 1.120 2.100 2.271 0 0
Totale 55.873